| NDC Code | 69680-145-30 |
|---|
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-145-30) |
|---|
| Product NDC | 69680-145 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Pramipexole Dihydrochloride |
|---|
| Proprietary Name Suffix | Extended-release |
|---|
| Non-Proprietary Name | Pramipexole Dihydrochloride |
|---|
| Dosage Form | TABLET, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20210827 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA212797 |
|---|
| Manufacturer | Vitruvias Therapeutics, Inc. |
|---|
| Substance Name | PRAMIPEXOLE DIHYDROCHLORIDE |
|---|
| Strength | .375 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC] |
|---|